Moderna (MRNA) Sliding Lower as EU Postpones Additional COVID Booster Deliveries, Pfizer (PFE) and Novavax (NVAX) on Watch

Go back to Moderna (MRNA) Sliding Lower as EU Postpones Additional COVID Booster Deliveries, Pfizer (PFE) and Novavax (NVAX) on Watch

UPDATE: Cowen Reiterates $150 PT on Novavax (NVAX), Believes 'briefing documents suggest that the vaccine meets all the requirements for approval '

June 3, 2022 11:23 AM EDT

(Updated - June 3, 2022 11:24 AM EDT)

Cowen analyst Georgi Yordanov reiterated an Outperform rating and $150.00 price target on Novavax (NASDAQ: NVAX).

The analyst comments " Overall, we believe the briefing documents suggest that the vaccine meets all the requirements for approval and we expect a positive vote at next week's meeting. As for the timing of a potential approval, the Agency does highlight that Novavax is yet to... More